Objective: The results of Interventional Management of Stroke (IMS) III, Magnetic Resonance
and REcanalization of Stroke Clots Using Embolectomy (MR RESCUE), and SYNTHESIS …

Acute ischemic stroke is a major cause of morbidity and mortality in developed countries.
Intravenous thrombolysis with tissue plasminogen activator (tPA) within 4.5 hours of …

Background and Purpose Thrombolysis> 4.5 hours after ischemic stroke onset is unproven.
We assessed the feasibility of tenecteplase (TNK) treatment in patients with evidence of an …

Background: Ischemic strokes with tandem occlusions are associated with a poor prognosis.
Recent studies demonstrating the effectiveness of endovascular treatment for large vessel …

Urgent reperfusion of the ischaemic brain is the aim of stroke treatment and there has been
ongoing research to find a drug that can promote vessel recanalisation more completely and …

The introduction of thrombolytic therapy in the 1990s has transformed acute ischemic stroke
treatment. Thus far, intravenous recombinant tissue plasminogen activator (rt-PA) also …

Thrombolytic therapy is one of the medical procedures in the treatment of acute ischaemic
stroke (AIS), whereby the tissue plasminogen activator (tPA) is intravenously administered to …

Aim Jasminoidin and ursodeoxycholic acid are 2 bioactive compounds extracted from C
hinese medicine that have been proven to exert a synergistic effect as a combined …

Background: In this study, we used CiteSpace and VOSviewer to create a bibliometric
visualization of research papers relating to stroke and magnetic resonance imaging (MRI) …

This study was undertaken to describe the still poorly known evolving profile of anterior
choroidal artery (AChA) infarctions, identify their prognosis factors, and evaluate responses …